Phosphatidylinositol 4-kinases: Function, structure, and inhibition.

[1]  M. Waring,et al.  Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα). , 2015, Bioorganic & medicinal chemistry letters.

[2]  M. Waugh.  PIPs in neurological diseases. , 2015, Biochimica et biophysica acta.

[3]  E. Bouřa,et al.  The high-resolution crystal structure of phosphatidylinositol 4-kinase IIβ and the crystal structure of phosphatidylinositol 4-kinase IIα containing a nucleoside analogue provide a structural basis for isoform-specific inhibitor design. , 2015, Acta crystallographica. Section D, Biological crystallography.

[4]  T. Balla,et al.  Polyphosphoinositide binding domains: Key to inositol lipid biology. , 2015, Biochimica et biophysica acta.

[5]  E. Bouřa,et al.  Highly Selective Phosphatidylinositol 4-Kinase IIIβ Inhibitors and Structural Insight into Their Mode of Action. , 2015, Journal of medicinal chemistry.

[6]  Roger L. Williams,et al.  Synergy in activating class I PI3Ks. , 2015, Trends in biochemical sciences.

[7]  P. De Camilli,et al.  Plasticity of PI4KIIIα interactions at the plasma membrane , 2015, EMBO reports.

[8]  Bartosz Różycki,et al.  Large, dynamic, multi-protein complexes: a challenge for structural biology , 2014, Journal of physics. Condensed matter : an Institute of Physics journal.

[9]  F. V. van Kuppeveld,et al.  GBF1- and ACBD3-Independent Recruitment of PI4KIIIβ to Replication Sites by Rhinovirus 3A Proteins , 2014, Journal of Virology.

[10]  H. Razavi,et al.  Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.

[11]  B. Różycki,et al.  The crystal structure of the phosphatidylinositol 4‐kinase IIα , 2014, EMBO reports.

[12]  R. De Francesco,et al.  NS5A Inhibitors Impair NS5A–Phosphatidylinositol 4-Kinase IIIα Complex Formation and Cause a Decrease of Phosphatidylinositol 4-Phosphate and Cholesterol Levels in Hepatitis C Virus-Associated Membranes , 2014, Antimicrobial Agents and Chemotherapy.

[13]  A. Gingras,et al.  Endosomal sorting of VAMP3 is regulated by PI4K2A , 2014, Journal of Cell Science.

[14]  L. Hamann,et al.  2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication. , 2014, Bioorganic & medicinal chemistry letters.

[15]  J. Neyts,et al.  Synthesis of Novel Purine‐Based Coxsackievirus Inhibitors Bearing Polycylic Substituents at the N‐9 Position , 2014, Archiv der Pharmazie.

[16]  V. Lohmann,et al.  Mapping of Functional Domains of the Lipid Kinase Phosphatidylinositol 4-Kinase Type III Alpha Involved in Enzymatic Activity and Hepatitis C Virus Replication , 2014, Journal of Virology.

[17]  J. Neyts,et al.  From norbornane-based nucleotide analogs locked in South conformation to novel inhibitors of feline herpes virus. , 2014, Bioorganic & medicinal chemistry.

[18]  Kevan M. Shokat,et al.  Structures of PI4KIIIβ complexes show simultaneous recruitment of Rab11 and its effectors , 2014, Science.

[19]  Hua Kang,et al.  Dual inhibition of EGFR at protein and activity level via combinatorial blocking of PI4KIIα as anti-tumor strategy , 2014, Protein & Cell.

[20]  S. Mukherjee,et al.  Legionella pneumophila Subversion of Host Vesicular Transport by SidC Effector Proteins , 2014, Traffic.

[21]  F. Sun,et al.  Puzzle out the regulation mechanism of PI4KIIα activity , 2014, Science China Life Sciences.

[22]  M. Waring,et al.  Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation. , 2014, Chemical Communications.

[23]  Siewert J Marrink,et al.  Mechanisms shaping cell membranes. , 2014, Current opinion in cell biology.

[24]  T. Balla,et al.  A novel probe for phosphatidylinositol 4-phosphate reveals multiple pools beyond the Golgi , 2014, The Journal of cell biology.

[25]  R. Goody,et al.  The structure of the N-terminal domain of the Legionella protein SidC. , 2014, Journal of structural biology.

[26]  K. Schulten,et al.  Molecular insights into the membrane-associated phosphatidylinositol 4-kinase IIα , 2014, Nature Communications.

[27]  R. Sinha,et al.  Piperine inhibits type II phosphatidylinositol 4-kinases: a key component in phosphoinositides turnover , 2014, Molecular and Cellular Biochemistry.

[28]  K. Taniguchi,et al.  A Complex Comprising Phosphatidylinositol 4-Kinase IIIβ, ACBD3, and Aichi Virus Proteins Enhances Phosphatidylinositol 4-Phosphate Synthesis and Is Critical for Formation of the Viral Replication Complex , 2014, Journal of Virology.

[29]  C. Moore,et al.  Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agents. , 2014, Journal of medicinal chemistry.

[30]  P. Janmey,et al.  Structural basis for PI(4)P-specific membrane recruitment of the Legionella pneumophila effector DrrA/SidM. , 2014, Structure.

[31]  P. De Camilli,et al.  Structural insights into assembly and regulation of the plasma membrane phosphatidylinositol 4-kinase complex. , 2014, Developmental cell.

[32]  T. Balla,et al.  Pharmacological and Genetic Targeting of the PI4KA Enzyme Reveals Its Important Role in Maintaining Plasma Membrane Phosphatidylinositol 4-Phosphate and Phosphatidylinositol 4,5-Bisphosphate Levels* , 2014, The Journal of Biological Chemistry.

[33]  Julie Tan,et al.  Cinderella story: PI4P goes from precursor to key signaling molecule , 2014, Critical reviews in biochemistry and molecular biology.

[34]  R. Jordan,et al.  Multiple Classes of Antiviral Agents Exhibit In Vitro Activity against Human Rhinovirus Type C , 2013, Antimicrobial Agents and Chemotherapy.

[35]  F. V. van Kuppeveld,et al.  Recruitment of PI4KIIIβ to Coxsackievirus B3 Replication Organelles Is Independent of ACBD3, GBF1, and Arf1 , 2013, Journal of Virology.

[36]  Robert W. Sauerwein,et al.  Targeting Plasmodium PI(4)K to eliminate malaria , 2013, Nature.

[37]  R. Sinha,et al.  Sanguinarine suppresses IgE induced inflammatory responses through inhibition of type II PtdIns 4-kinase(s). , 2013, Archives of biochemistry and biophysics.

[38]  P. Vidalain,et al.  The Golgi Protein ACBD3, an Interactor for Poliovirus Protein 3A, Modulates Poliovirus Replication , 2013, Journal of Virology.

[39]  R. Sinha,et al.  Type II phosphatidylinositol 4-kinase β is an integral signaling component of early T cell activation mechanisms. , 2013, Biochimie.

[40]  C. Lacroix,et al.  A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ , 2013, Antimicrobial Agents and Chemotherapy.

[41]  S. Eom,et al.  Structure of Osh3 reveals a conserved mode of phosphoinositide binding in oxysterol-binding proteins. , 2013, Structure.

[42]  T. Balla,et al.  Phosphoinositides: tiny lipids with giant impact on cell regulation. , 2013, Physiological reviews.

[43]  R. Dzijak,et al.  Involvement of phosphatidylinositol 4,5-bisphosphate in RNA polymerase I transcription , 2013, Journal of Cell Science.

[44]  J. Neyts,et al.  Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections. , 2013, ACS medicinal chemistry letters.

[45]  O. Hucke,et al.  Phosphatidylinositol 4-Kinase III Beta Is Essential for Replication of Human Rhinovirus and Its Inhibition Causes a Lethal Phenotype In Vivo , 2013, Antimicrobial Agents and Chemotherapy.

[46]  R. Bartenschlager,et al.  The Lipid Kinase Phosphatidylinositol-4 Kinase III Alpha Regulates the Phosphorylation Status of Hepatitis C Virus NS5A , 2013, PLoS pathogens.

[47]  S. Minogue,et al.  Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks , 2013, Progress in Lipid Research.

[48]  J. Derisi,et al.  ACBD3 Interaction with TBC1 Domain 22 Protein Is Differentially Affected by Enteroviral and Kobuviral 3A Protein Binding , 2013, mBio.

[49]  S. Minogue,et al.  Phosphatidylinositol 4-Kinases and PI4P Metabolism in the Nervous System: Roles in Psychiatric and Neurological Diseases , 2013, Molecular Neurobiology.

[50]  M. Waugh.  Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer. , 2012, Cancer letters.

[51]  Sang Yoon Lee,et al.  PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity , 2012, The Journal of cell biology.

[52]  V. Haucke,et al.  Phosphatidylinositol 4‐kinase IIα function at endosomes is regulated by the ubiquitin ligase Itch , 2012, EMBO reports.

[53]  P. Cossart,et al.  Entry of Listeria monocytogenes in mammalian epithelial cells: an updated view. , 2012, Cold Spring Harbor perspectives in medicine.

[54]  Gerhard Hummer,et al.  Membrane-Elasticity Model of Coatless Vesicle Budding Induced by ESCRT Complexes , 2012, PLoS Comput. Biol..

[55]  D. Klionsky,et al.  Phosphatidylinositol 4-Kinases Are Required for Autophagic Membrane Trafficking* , 2012, The Journal of Biological Chemistry.

[56]  G. Kukolj,et al.  Evaluation of Phosphatidylinositol-4-Kinase IIIα as a Hepatitis C Virus Drug Target , 2012, Journal of Virology.

[57]  T. Balla,et al.  PI4P and PI(4,5)P2 Are Essential But Independent Lipid Determinants of Membrane Identity , 2012, Science.

[58]  L. Delang,et al.  The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication , 2012, Biochemical Pharmacology.

[59]  P. Raman,et al.  Anti-Hepatitis C Virus Activity and Toxicity of Type III Phosphatidylinositol-4-Kinase Beta Inhibitors , 2012, Antimicrobial Agents and Chemotherapy.

[60]  J. Hurley,et al.  Endosomal Sorting Complex Required for Transport (ESCRT) Complexes Induce Phase-separated Microdomains in Supported Lipid Bilayers* , 2012, The Journal of Biological Chemistry.

[61]  A. Mattarei,et al.  Resveratrol and Health: The Starting Point , 2012, Chembiochem : a European journal of chemical biology.

[62]  T. Balla,et al.  Phosphatidylinositol 4-kinases: hostages harnessed to build panviral replication platforms , 2012, Trends in Biochemical Sciences.

[63]  M. Fukata,et al.  Phosphatidylinositol 4-Kinase IIα Is Palmitoylated by Golgi-localized Palmitoyltransferases in Cholesterol-dependent Manner* , 2012, The Journal of Biological Chemistry.

[64]  A. Gingras,et al.  Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, β-glucocerebrosidase , 2012, Molecular biology of the cell.

[65]  R. De Francesco,et al.  Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity , 2012, PLoS pathogens.

[66]  M. Arita,et al.  ACBD3‐mediated recruitment of PI4KB to picornavirus RNA replication sites , 2012, The EMBO journal.

[67]  J. Derisi,et al.  The 3A Protein from Multiple Picornaviruses Utilizes the Golgi Adaptor Protein ACBD3 To Recruit PI4KIIIβ , 2012, Journal of Virology.

[68]  J. Hurley,et al.  Structural basis for membrane targeting by the MVB12-associated β-prism domain of the human ESCRT-I MVB12 subunit , 2012, Proceedings of the National Academy of Sciences.

[69]  S. Shankar,et al.  Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. , 2011, Biochemical pharmacology.

[70]  R. Sinha,et al.  Epigallocatechin gallate (EGCG) inhibits type II phosphatidylinositol 4-kinases: a key component in pathways of phosphoinositide turnover. , 2011, Archives of biochemistry and biophysics.

[71]  A. Tai,et al.  The Role of the Phosphatidylinositol 4-Kinase PI4KA in Hepatitis C Virus-Induced Host Membrane Rearrangement , 2011, PloS one.

[72]  T. Balla,et al.  A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases. , 2011, Analytical biochemistry.

[73]  Anthony Bretscher,et al.  Membrane-trafficking sorting hubs: cooperation between PI4P and small GTPases at the trans-Golgi network. , 2011, Trends in cell biology.

[74]  G. Randall,et al.  Hepatitis C Virus Stimulates the Phosphatidylinositol 4-Kinase III Alpha-Dependent Phosphatidylinositol 4-Phosphate Production That Is Essential for Its Replication , 2011, Journal of Virology.

[75]  Gerhard Hummer,et al.  Solution structure of the ESCRT-I complex by small-angle X-ray scattering, EPR, and FRET spectroscopy , 2011, Proceedings of the National Academy of Sciences.

[76]  T. Misteli,et al.  Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk). , 2011, Bioorganic & medicinal chemistry letters.

[77]  H. Shu,et al.  Stabilization of Phosphatidylinositol 4-Kinase Type IIβ by Interaction with Hsp90* , 2011, The Journal of Biological Chemistry.

[78]  D. Sabatini,et al.  Mammalian Target of Rapamycin ( mTOR ) Inhibitor for Treatment of Cancer , 2011 .

[79]  Y. Lim,et al.  Hepatitis C Virus NS5A Protein Interacts with Phosphatidylinositol 4-Kinase Type IIIα and Regulates Viral Propagation* , 2011, The Journal of Biological Chemistry.

[80]  Thomas Lengauer,et al.  Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. , 2011, Cell host & microbe.

[81]  T. Wakita,et al.  Phosphatidylinositol 4-Kinase III Beta Is a Target of Enviroxime-Like Compounds for Antipoliovirus Activity , 2010, Journal of Virology.

[82]  P. Janmey,et al.  Kinase Associated-1 Domains Drive MARK/PAR1 Kinases to Membrane Targets by Binding Acidic Phospholipids , 2010, Cell.

[83]  L. Rezabkova,et al.  Structure of the human FOXO4-DBD-DNA complex at 1.9 Å resolution reveals new details of FOXO binding to the DNA. , 2010, Acta crystallographica. Section D, Biological crystallography.

[84]  J. Yoon,et al.  Helicobacter pylori proinflammatory protein up-regulates NF-κB as a cell-translocating Ser/Thr kinase , 2010, Proceedings of the National Academy of Sciences.

[85]  T. Kutateladze,et al.  Translation of the phosphoinositide code by PI effectors. , 2010, Nature chemical biology.

[86]  L. Rezabkova,et al.  14-3-3 protein interacts with and affects the structure of RGS domain of regulator of G protein signaling 3 (RGS3). , 2010, Journal of structural biology.

[87]  C. Cameron,et al.  Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication , 2010, Cell.

[88]  J. Li,et al.  VAV2 regulates epidermal growth factor receptor endocytosis and degradation , 2010, Oncogene.

[89]  M. Scidmore,et al.  Multiple Host Proteins That Function in Phosphatidylinositol-4-Phosphate Metabolism Are Recruited to the Chlamydial Inclusion , 2010, Infection and Immunity.

[90]  D. Lavillette,et al.  Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  John A. Tallarico,et al.  Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication , 2009, Journal of Virology.

[92]  J. Hsuan,et al.  Loss of phosphatidylinositol 4-kinase 2α activity causes late onset degeneration of spinal cord axons , 2009, Proceedings of the National Academy of Sciences.

[93]  Dianqing Wu,et al.  Regulation of Phosphatidylinositol Kinases and Metabolism by Wnt3a and Dvl* , 2009, The Journal of Biological Chemistry.

[94]  N. Heaton,et al.  Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication , 2009, Proceedings of the National Academy of Sciences.

[95]  G. Kukolj,et al.  Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. , 2009, Virology.

[96]  Raymond T Chung,et al.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. , 2009, Cell host & microbe.

[97]  H. Hilbi,et al.  Rab1 Guanine Nucleotide Exchange Factor SidM Is a Major Phosphatidylinositol 4-Phosphate-binding Effector Protein of Legionella pneumophila , 2009, Journal of Biological Chemistry.

[98]  P. De Camilli,et al.  Mutations in phosphoinositide metabolizing enzymes and human disease. , 2009, Physiology.

[99]  S. Emr,et al.  Assembly of the PtdIns 4-kinase Stt4 complex at the plasma membrane requires Ypp1 and Efr3 , 2008, The Journal of cell biology.

[100]  Dianqing Wu,et al.  Wnt3a-Mediated Formation of Phosphatidylinositol 4,5-Bisphosphate Regulates LRP6 Phosphorylation , 2008, Science.

[101]  Giovanni D'Angelo,et al.  The multiple roles of PtdIns(4)P – not just the precursor of PtdIns(4,5)P2 , 2008, Journal of Cell Science.

[102]  Seng-Lai Tan,et al.  NS5A--from obscurity to new target for HCV therapy. , 2008, Recent patents on anti-infective drug discovery.

[103]  V. Faundez,et al.  Phosphatidylinositol-4-kinase type II alpha contains an AP-3-sorting motif and a kinase domain that are both required for endosome traffic. , 2008, Molecular biology of the cell.

[104]  Michael L. Gonzales,et al.  A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs , 2008, Nature.

[105]  K. Shokat,et al.  Design of drug-resistant alleles of type-III phosphatidylinositol 4-kinases using mutagenesis and molecular modeling. , 2008, Biochemistry.

[106]  H. Shu,et al.  Molecular determinants of activation and membrane targeting of phosphoinositol 4-kinase IIbeta. , 2008, The Biochemical journal.

[107]  J. Thorner,et al.  Structural Insights into Activation of Phosphatidylinositol 4-Kinase (Pik1) by Yeast Frequenin (Frq1)* , 2007, Journal of Biological Chemistry.

[108]  P. Cossart,et al.  Type II phosphatidylinositol 4‐kinases promote Listeria monocytogenes entry into target cells , 2007, Cellular microbiology.

[109]  J. Bonifacino,et al.  PI4P promotes the recruitment of the GGA adaptor proteins to the trans-Golgi network and regulates their recognition of the ubiquitin sorting signal. , 2007, Molecular biology of the cell.

[110]  G. D’Angelo,et al.  Lipid-transfer proteins in membrane trafficking at the Golgi complex. , 2007, Biochimica et biophysica acta.

[111]  Kevan M Shokat,et al.  Phosphatidylinositol 4-Kinase IIIβ Regulates the Transport of Ceramide between the Endoplasmic Reticulum and Golgi* , 2006, Journal of Biological Chemistry.

[112]  K. Pfizenmaier,et al.  Phospho-specific binding of 14-3-3 proteins to phosphatidylinositol 4-kinase III β protects from dephosphorylation and stabilizes lipid kinase activity , 2006, Journal of Cell Science.

[113]  T. Balla,et al.  Phosphatidylinositol 4-kinases: old enzymes with emerging functions. , 2006, Trends in cell biology.

[114]  Alice Hlobilkova,et al.  Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. , 2006, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[115]  Robbie Loewith,et al.  A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling , 2006, Cell.

[116]  H. Hilbi,et al.  Legionella pneumophila Exploits PI(4)P to Anchor Secreted Effector Proteins to the Replicative Vacuole , 2006, PLoS pathogens.

[117]  J. Hsuan,et al.  Lipid and Peptide Control of Phosphatidylinositol 4-Kinase IIα Activity on Golgi-endosomal Rafts* , 2006, Journal of Biological Chemistry.

[118]  J. Thorner,et al.  Yeast phosphatidylinositol 4-kinase, Pik1, has essential roles at the Golgi and in the nucleus , 2005, The Journal of cell biology.

[119]  G. Carman,et al.  A WASp-binding type II phosphatidylinositol 4-kinase required for actin polymerization-driven endosome motility , 2005, The Journal of cell biology.

[120]  D. Panda,et al.  Resveratrol inhibits type II phosphatidylinositol 4-kinase: a key component in pathways of phosphoinositide turn over. , 2005, Biochemical pharmacology.

[121]  Peter Storz,et al.  Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIβ at the Golgi complex , 2005, Nature Cell Biology.

[122]  K. Hoe,et al.  Systematic identification of hepatocellular proteins interacting with NS5A of the hepatitis C virus. , 2004, Journal of biochemistry and molecular biology.

[123]  S. Hilfiker.  Neuronal calcium sensor-1: a multifunctional regulator of secretion. , 2003, Biochemical Society transactions.

[124]  B. Horazdovsky,et al.  Saccharomyces cerevisiae contains a Type II phosphoinositide 4-kinase. , 2003, The Biochemical journal.

[125]  S. Emr,et al.  The Saccharomyces cerevisiae LSB6 Gene Encodes Phosphatidylinositol 4-Kinase Activity* , 2002, The Journal of Biological Chemistry.

[126]  K. Kunii,et al.  Type II Phosphatidylinositol 4-Kinase β Is a Cytosolic and Peripheral Membrane Protein That Is Recruited to the Plasma Membrane and Activated by Rac-GTP* , 2002, The Journal of Biological Chemistry.

[127]  Scott D Emr,et al.  Stt4 PI 4-kinase localizes to the plasma membrane and functions in the Pkc1-mediated MAP kinase cascade. , 2002, Developmental cell.

[128]  R. Ghirlando,et al.  Crystal Structure of the 14-3-3ζ:Serotonin N-Acetyltransferase Complex A Role for Scaffolding in Enzyme Regulation , 2001, Cell.

[129]  G. Vereb,et al.  Synthesis of new cyclitol compounds that influence the activity of phosphatidylinositol 4-kinase isoform, PI4K230. , 2001, Journal of medicinal chemistry.

[130]  M. Foti,et al.  Distinct roles for the yeast phosphatidylinositol 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane dynamics. , 2000, Molecular biology of the cell.

[131]  P. A. Harris,et al.  The discovery of potent cRaf1 kinase inhibitors. , 2000, Bioorganic & medicinal chemistry letters.

[132]  A. Luini,et al.  ARF mediates recruitment of PtdIns-4-OH kinase-β and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex , 1999, Nature Cell Biology.

[133]  K. Umezawa,et al.  Synthesis and inhibitory activity against phosphatidylinositol 4-kinase of echiguanine analogs. , 1999, Nucleosides & nucleotides.

[134]  K. Umezawa,et al.  Synthesis and structure-activity relationship of ribofuranosyl echiguanine analogs as inhibitors of phosphatidylinositol 4-kinase , 1998 .

[135]  L. Heilmeyer,et al.  Phosphatidylinositol 4-kinases. , 1998, European journal of biochemistry.

[136]  M. Burger,et al.  Chromaffin granule‐associated phosphatidylinositol 4‐kinase activity is required for stimulated secretion. , 1996, The EMBO journal.

[137]  K. Catt,et al.  Characterization of a soluble adrenal phosphatidylinositol 4-kinase reveals wortmannin sensitivity of type III phosphatidylinositol kinases. , 1996, Biochemistry.

[138]  C. Sander,et al.  Dali: a network tool for protein structure comparison. , 1995, Trends in biochemical sciences.

[139]  L. Vance,et al.  The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus , 1995, Journal of virology.

[140]  K. Catt,et al.  A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[141]  R. L. Singhal,et al.  Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. , 1995, Life sciences.

[142]  J. Dodge,et al.  Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. , 1994, Cancer research.

[143]  M. Hall,et al.  PIK1, an essential phosphatidylinositol 4‐kinase associated with the yeast nucleus. , 1994, The EMBO journal.

[144]  M. Goebl,et al.  A novel gene, STT4, encodes a phosphatidylinositol 4-kinase in the PKC1 protein kinase pathway of Saccharomyces cerevisiae. , 1994, The Journal of biological chemistry.

[145]  J. Thorner,et al.  Phosphatidylinositol 4-kinase: gene structure and requirement for yeast cell viability. , 1993, Science.

[146]  J. Thorner,et al.  Purification and characterization of a soluble phosphatidylinositol 4-kinase from the yeast Saccharomyces cerevisiae. , 1992, The Journal of biological chemistry.

[147]  L. Cantley,et al.  Purification and characterization of human erythrocyte phosphatidylinositol 4-kinase. Phosphatidylinositol 4-kinase and phosphatidylinositol 3-monophosphate 4-kinase are distinct enzymes. , 1992, The Biochemical journal.

[148]  G. Barritt,et al.  Purification and chemical modification of a phosphatidylinositol kinase from sheep brain. , 1991, European journal of biochemistry.

[149]  H. Naganawa,et al.  Isolation and structure determination of novel phosphatidylinositol kinase inhibitors, echiguanines A and B, from Streptomyces sp. , 1991, Journal of natural products.

[150]  K. Umezawa,et al.  Inhibition of phosphatidylinositol kinase by toyocamycin. , 1990, The Journal of antibiotics.

[151]  R. C. Young,et al.  Purine derivatives as competitive inhibitors of human erythrocyte membrane phosphatidylinositol 4-kinase. , 1990, Journal of medicinal chemistry.

[152]  K. Umezawa,et al.  Screening of phosphatidylinositol kinase inhibitors from Streptomyces. , 1989, The Journal of antibiotics.

[153]  P. Hawkins,et al.  Metabolic and structural evidence for the existence of a third species of polyphosphoinositide in cells: D-phosphatidyl-myo-inositol 3-phosphate. , 1989, The Biochemical journal.

[154]  D. Kaplan,et al.  Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation. , 1987, The Biochemical journal.

[155]  L. Naesens,et al.  Norbornane-based nucleoside and nucleotide analogues locked in North conformation. , 2015, Bioorganic & medicinal chemistry.

[156]  E. Ruelland,et al.  Signal transduction pathways involving phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate: convergences and divergences among eukaryotic kingdoms. , 2013, Progress in lipid research.

[157]  G. D’Angelo,et al.  Phosphoinositides in Golgi complex function. , 2012, Sub-cellular biochemistry.

[158]  B. Różycki,et al.  Membrane Budding , 2010, Cell.

[159]  L. Cantley,et al.  Purification and characterization of human erythrocyte phosphatidylinositol 4-kinase , 2005 .